Integrated Genomic Analysis Implicates Haploinsufficiency of Multiple Chromosome 5q31.2 Genes in De Novo Myelodysplastic Syndromes Pathogenesis-Reference-Cited by-同舟云学术

Integrated Genomic Analysis Implicates Haploinsufficiency of Multiple Chromosome 5q31.2 Genes in De Novo Myelodysplastic Syndromes Pathogenesis

Published:2009-02-25 Issue:2 Volume:4 Page:e4583
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Graubert Timothy A.,Payton Michelle A.,Shao Jin,Walgren Richard A.,Monahan Ryan S.,Frater John L.,Walshauser Mark A.,Martin Mike G.,Kasai Yumi,Walter Matthew J.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference24 articles.

1. Evaluation of recurring cytogenetic abnormalities in the treatment of myelodysplastic syndromes.;HJ Olney;Leukemia research,2007

2. Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases.;MM Le Beau;Proceedings of the National Academy of Sciences of the United States of America,1993

3. Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1–1.5 Mb and preparation of a PAC-based physical map.;N Zhao;Proceedings of the National Academy of Sciences of the United States of America,1997

4. Narrowing and genomic annotation of the commonly deleted region of the 5q- syndrome.;J Boultwood;Blood,2002

5. Delineation of a minimal interval and identification of 9 candidates for a tumor suppressor gene in malignant myeloid disorders on 5q31.;SK Horrigan;Blood,2000

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HSPA9/mortalin inhibition disrupts erythroid maturation through a TP53-dependent mechanism in human CD34+ hematopoietic progenitor cells;Cell Stress and Chaperones;2024-04

2. DeepPRMS: advanced deep learning model to predict protein arginine methylation sites;Briefings in Functional Genomics;2024-01-24

3. Genome-wide DNA methylation analysis pre- and post-lenalidomide treatment in patients with myelodysplastic syndrome with isolated deletion (5q);Annals of Hematology;2021-04-27

4. Loss of 5q in myeloid malignancies – A gain in understanding of biological and clinical consequences;Blood Reviews;2021-03

5. Loss of lenalidomide-induced megakaryocytic differentiation leads to therapy resistance in del(5q) myelodysplastic syndrome;Nature Cell Biology;2020-04-06